Skip to evidence report

T.CD4_Tem.transitional_CM: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 2,070 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for T.CD4_Tem.transitional_CM
#Trait / studyIndividual trait IDMean IC score
1Allergic contact dermatitisFING0000006854.10
2CD5/TNFRSF9 ratioGCST9031386251.78
3Second line medication for Crohn's diseaseFING0000128451.17
4Psoriasis vulgaris (PheCode 696.41)GCST9047619047.58
5Papulosquamous disordersFING0000114447.05
6Nasal polypFING0000085847.01
7Psoriatic arthritisGCST9024395646.31
8Reimbursement for rheumatic diseasesFING0000124745.93
9Psoriasis (PheCode 696.4)GCST9047618745.57
10Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditionsUKBB0000051845.37
11Hypothyroidism | endocrine/metabolicUKBB0000033544.88
12Psoriasis and related disorder (PheCode 696)GCST9047618644.34
13Other hypothyroidism | Disorders of thyroid glandUKBB0000061143.29
14CXCL9 levelsGCST9046893543.27
15Autoimmune diseases excluding thyroid diseasesFING0000013243.16
16Treatment/medication code - levothyroxine sodium | MedicationsUKBB0000084943.00
17Hypothyroidism NOS | endocrine/metabolicUKBB0000033642.75
18TNFRSF8 levelsGCST9047091542.48
19Rheumatoid arthritisFING0000126742.21
20Seropositive rheumatoid arthritis, strict definitionFING0000129741.94
21Multiple sclerosisGCST9047583341.75
22HypothyroidismGCST9046813841.71
23HypothyroidismGCST9020416740.99
24CD5 levelsGCST9046864140.75
25Other/unspecified rheumatoid arthritisFING0000112640.40
26Lymphocyte countGCST9001874240.36
27Thyroid problemsGCST9047527640.32
28Disorders of the thyroid glandFING0000046339.84
29Autoimmune diseasesFING0000013139.52
30Suggestive for eosinophilic asthmaFING0000134439.22
31Hypothyroidism NOS (PheCode 244.4)GCST9047565339.14
32Hypothyroidism (PheCode 244)GCST9047564739.07
33Lymphocyte countGCST9002598438.89
34PAFAH1B3 levelsGCST9047014538.67
35Asthma | Chronic lower respiratory diseasesUKBB0000005338.64
36Hypothyroidism, strict autoimmuneFING0000065638.26
37Lymphocyte countGCST9000231737.97
38Asthma | respiratoryUKBB0000005437.97
39Asthma-related infectionsFING0000011837.73
40Psoriasis vulgarisFING0000122437.34
41Eosinophill percentage (UKB data field 30210)GCST9046806936.71
42CD48/CRTAM ratioGCST9031383936.67
43Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044)GCST9004253536.61
44MS-disease / Multiple SclerosisFING0000083936.45
45ITGAL levelsGCST9046963735.94
46Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)FING0000075635.89
47Takes medication for Thyroid problems?GCST9047527735.63
48HypothyroidismGCST9031932035.41
49Asthma-related acute respiratory infectionsFING0000011735.37
50lymphocyte (absolute count, mean, inv-norm transformed)GCST9047542635.29
51TXNL1 levelsGCST9047099335.25
52Type 1 diabetesGCST9001379135.23
53SKAP1 levelsGCST9047064534.94
54HyperthyroidismGCST9046813634.84
55Prescriptions - levothyroxine | thyroid hormoneUKBB0000068734.72
56Prescriptions - thyroid hormone | hormoneUKBB0000070534.72
57Lymphoid neoplasms (B-cell phenocluster)GCST9062473634.71
58Seropositive rheumatoid arthritis, wideFING0000129834.68
59FCRL6 levelsGCST9046920934.68
60Type 1 diabetesGCST9001402334.65
61lymphocyte (absolute count, maximum, inv-norm transformed)GCST9047542334.63
62Thyroid peroxidase antibody levels in pregnancyGCST9043520134.62
63Atopic dermatitisFING0000012534.31
64Lymphoid neoplasms (somatic mutation group 2 phenocluster)GCST9062475034.29
65Dermatitis and eczemaFING0000040234.27
66Thyroid peroxidase antibody positivity in pregnancyGCST9043520234.20
67Type 1 diabetesGCST9000052933.81
68Nasal polyps (PheCode 471)GCST9047601933.81
69Lymphoid neoplasmsGCST9062474333.79
70Asthma/COPD (KELA code 203)FING0000012133.73
71CRTAM/VCAM1 ratioGCST9031428133.67
72Eosinophill count | Blood countUKBB0000020633.53
73Eosinophill percentage | Blood countUKBB0000020733.43
74Chronic sinusitisFING0000029833.35
75Lymphoid neoplasms (drug group 1 phenocluster)GCST9062474032.99
76Graves disease, strict definitionFING0000059232.88
77Non-cancer illness code, self-reported - eczema/dermatitis | Medical conditionsUKBB0000050932.81
78Eosinophil percentage of white cellsGCST9000238232.68
79First line medication for Crohn's diseaseFING0000054432.56
80Eosinophil percentage of white cellsGCST00460032.20
81CD160/KLRB1 ratioGCST9031373132.14
82lymphocyte (absolute count, minimum, inv-norm transformed)GCST9047542932.14
83ThyrotoxicosisFING0000136031.92
84Asthma (only as main-diagnosis) (more control exclusions)FING0000011431.66
85Eosinophil percentage of granulocytesGCST00461731.56
86CD244/CRTAM ratioGCST9031376331.38
87Asthma (childhood onset)GCST00780031.07
88Chronic lower respiratory diseasesFING0000029030.94
89Lymphocyte count | Blood countUKBB0000041130.93
90Coeliac diseaseGCST9046812030.76
91Eosinophil countGCST00460630.64
92Allergic disease (asthma, hay fever or eczema)GCST00503830.47
93Rheumatoid arthritisGCST9013222330.35
94Neutrophil percentage of granulocytesGCST00462330.28
95AsthmaGCST9046811230.20
96Asthma (more control exclusions)FING0000011330.07
97Lymphocyte count (UKB data field 30120)GCST9046808230.04
98CXCL16 levelsGCST9046892830.03
99eosinophil (absolute count, mean, inv-norm transformed)GCST9047529130.02
100Primary biliary cholangitisGCST9006144029.94
101Atopic dermatitisGCST9002716129.93
102eosinophil (fraction, maximum, inv-norm transformed)GCST9047529729.61
103eosinophil (fraction, mean, inv-norm transformed)GCST9047530029.43
104Noninfective enteritis and colitisFING0000088129.43
105AsthmaGCST01004229.43
106Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditionsUKBB0000010129.32
107Thyroid peroxidase antibody positivity with euthyroid in pregnancyGCST9043520329.22
108eosinophil (fraction, minimum, inv-norm transformed)GCST9047530329.08
109TNFRSF17 levelsGCST9047090829.02
110CRTAM/FCRL6 ratioGCST9031427428.96
111Thyrotoxicosis with diffuse goitreFING0000136128.90
112eosinophil (absolute count, maximum, inv-norm transformed)GCST9047528828.86
113Eosinophil countGCST9000229828.82
114Eosinophill count (UKB data field 30150)GCST9046806828.78
115Eosinophil countGCST9000238128.64
116Lymphocyte countGCST9000238828.60
117Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditionsUKBB0000010028.59
118Hypothyroidism, drug reimbursementFING0000065528.55
119GZMA/GZMH ratioGCST9031500828.48
120PsoriasisFING0000122228.30
121Lymphocyte countGCST9000231628.18
122Lymphocyte countGCST00462728.12
123IL2RB levelsGCST9046958627.91
124eosinophil (absolute count, minimum, inv-norm transformed)GCST9047529427.89
125GZMA/GZMB ratioGCST9031500727.80
126Childhood asthma (age<16) (more control exclusions)FING0000027027.73
127HyperthyroidismGCST9031931927.55
128CD160/CXCL16 ratioGCST9031372827.47
129Asthma (adult onset)GCST00779927.44
130CD6 levelsGCST9046864427.35
131CRTAM/LY9 ratioGCST9031427827.07
132Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditionsUKBB0000009827.06
133PolyarthropathiesFING0000118027.00
134Other (seronegative) rheumatoid arthritis, wideFING0000091726.99
135Pain type(s) experienced in last month - Pain all over the body | PainUKBB0000063226.93
136PsoriasisGCST9001901626.90
137Sum eosinophil basophil countsGCST00462426.87
138PAG1 levelsGCST9047014726.75
139PDCD1 levelsGCST9047018126.68
140Eosinophil countGCST9000229926.51
141Rheumatoid arthritisGCST9013222426.45
142Mosaic chromosomal alteration of the X chromosomeGCST9016528726.35
143MZB1 levelsGCST9046998726.28
144MAVS/TBL1X ratioGCST9031539926.21
145AsthmaGCST9001432526.15
146Left-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST9030270625.86
147NCR1 levelsGCST9047000925.80
148KLRB1 levelsGCST9046970925.79
149CD79B/TNFRSF4 ratioGCST9031390325.64
150EndometriosisGCST9001861925.38
151IL15 levelsGCST9046955625.13
152Respiratory disease (confirmatory factor analysis Factor 11)GCST9030934525.11
153Systemic lupus erythematosusGCST9001186625.06
154HLAE/IL15 ratioGCST9031506125.06
155Eosinophil countGCST9001873324.95
156CD8A levelsGCST9046865524.93
157LTA levelsGCST9046981324.87
158PALM2 levelsGCST9047015224.86
159Autoimmune hyperthyroidismFING0000013424.79
160Non-cancer illness code, self-reported - asthma | Medical conditionsUKBB0000050624.62
161OSMR levelsGCST9047013224.58
162Rheumatoid arthritisGCST9001869024.55
163Ceramide (d18:2/22:0) levelsGCST9002468224.46
164GZMH levelsGCST9046942524.42
165Sicca syndrome [Sjögren]FING0000130424.34
166Disorders of orbitFING0000044924.31
167HSIL lesion of the cervix uteriFING0000062424.22
168Type1 diabetes, definitions combined, early onsetFING0000138424.14
169Allergy/adverse effect of penicillin | injuries & poisoningsUKBB0000002824.08
170Graves' diseaseGCST9001862723.99
171Basal cell carcinoma (MTAG)GCST9013741123.90
172Crohn disease (strict definition, require KELA, min 2 HDR)FING0000036623.89
173Other diseases of upper respiratory tractFING0000101223.82
174EczemaGCST9046812623.78
175Asthma and allergyFING0000011523.66
176IL15/IL18BP ratioGCST9031514823.62
177IL5RA/TNFRSF13B ratioGCST9031516423.52
178T1 FreeSurfer aseg MaskVol-to-eTIVGCST9038419223.52
179Eosinophil countGCST9002598723.48
180Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditionsUKBB0000051323.46
181GNLY levelsGCST9046937223.42
182BLNK levelsGCST9046844823.32
183Atopic/contact dermatitis due to other or unspecified (PheCode 939)GCST9047628923.17
184Coeliac diseaseFING0000031223.13
185Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB0000001523.10
186CD160 levelsGCST9046859922.80
187Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB0000064122.76
188GZMB/IL15 ratioGCST9031501522.70
189AsthmaGCST00686222.67
190SIT1 levelsGCST9047064422.65
191HSIL lesion of the cervix uteri, vagina or vulvaFING0000062522.63
192Blood cell traits latent factor 9 (white cell)GCST9055925122.63
193Rash and other nonspecific skin eruption (PheCode 687.1)GCST9047616722.61
194GZMB levelsGCST9046942422.58
195Nasal polyps | respiratoryUKBB0000049422.53
196Diseases of hair and hair follicles (PheCode 704)GCST9047620922.48
197SH2B3/TBL1X ratioGCST9031584122.47
198Allergic asthma (mode)FING0000006622.34
199Lichen ruber planus, wide definition including periferal and oral lichen planusFING0000072222.31
200Myasthenia gravisGCST9043215622.30
201SarcoidosisGCST9050348322.16
202Mouth/teeth dental problems - Mouth ulcers | MouthUKBB0000048822.08
203DNAJC21 levelsGCST9046901622.00
204Rheumatoid arthritisGCST00067921.98
205CD160/NCR1 ratioGCST9031373221.95
206Inflammatory bowel disease, strict (require KELA)FING0000067521.92
207CRTAM levelsGCST9046887121.84
208PDCD1/TNFRSF8 ratioGCST9031561021.79
209CD244/FCRL6 ratioGCST9031376521.78
210Mouth/teeth dental problems - None of the above | MouthUKBB0000048921.74
211CD8 on Effector Memory CD8+ T cellGCST9000205621.70
212CD27/DLL1 ratioGCST9031377121.47
213Monoclonal gammopathy of undetermined significanceGCST9062474521.37
214FCRL5/LY96 ratioGCST9031480321.30
215Lichen sclerosus et atrophicusFING0000072321.30
216IL1RL1 levelsGCST9046957421.20
217Left-hemisphere control network to amygdala white-matter structural connectivityGCST9030275721.19
218Handedness (chirality/laterality) - Left-handed | Early life factorsUKBB0000030221.15
219HippSubfield lh volume Hippocampal-tailGCST9000266821.11
220BMP7 levelsGCST9008815721.08
221PsoriasisGCST9046814720.92
222Neurofibromatosis, type 2FING0000086720.91
223Overweight, obesity and other hyperalimentation | endocrine/metabolicUKBB0000062220.69
224CXCL10 levelsGCST9046892320.64
225RBFOX3 levelsGCST9047043220.50
226Type 1 diabetes, definitions combinedFING0000138020.49
227Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050239620.38
228CLC levelsGCST9046876220.34
229Pulmonary fibrosisGCST9001868820.33
230Seborrheic dermatitis (PheCode 690.1)GCST9047617120.24
231Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)GCST9013222720.15
232Erythematosquamous dermatosis (PheCode 690)GCST9047617019.99
233Medication use (drugs affecting bone structure and mineralization)GCST9001877319.92
234Type 1 diabetesGCST9043206619.91
235Nasal polyp | Other diseases of upper respiratory tractUKBB0000049319.89
236Preterm labour and deliveryFING0000120919.81
237IridocyclitisFING0000069619.80
238CRTAM/TNFRSF9 ratioGCST9031428019.76
239Obesity related asthmaFING0000089719.73
240CD27/TGFBR2 ratioGCST9031377619.67
241CCL17/PDGFB ratioGCST9031368819.66
242Asthma with exacerbation (PheCode 495.2)GCST9047602519.42
243Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555)GCST9047606519.24
244IDO1 levelsGCST9046950619.23
245RPE levelsGCST9047049519.22
246Graves' disease (PheCode 242.1)GCST9047564419.11
247Smoking status (weighted GWA)GCST9026730319.00
248CD27/NBL1 ratioGCST9031377418.99
249Primary biliary cholangitisGCST00312918.96
250Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41)GCST9066848518.95
251CD48/FCRL6 ratioGCST9031384018.86
252Chromatiales abundance in stoolGCST9003231818.78
253Systemic connective tissue disordersFING0000135018.76
254Avoided activities or situations because of previous stressful experience in past month | Traumatic eventsUKBB0000008318.74
255Operation code - tonsillectomy +/- adenoids | OperationsUKBB0000056718.70
256HippSubfield lh volume GC-ML-DG-headGCST9000267918.69
257Paraproteinemia (PheCode 270.32)GCST9047571018.61
258SH2D1A levelsGCST9047061718.57
259GNLY/GZMA ratioGCST9031494918.57
260X-21285 levelsGCST9020057618.46
261Cervical cancerGCST9001181618.41
262GRAP2/SRC ratioGCST9031498918.38
263Interpolated Year when non-cancer illness first diagnosed | Medical conditionsUKBB0000037118.34
264Lymphocyte percentage | Blood countUKBB0000041218.34
265Seborrhoeic dermatitisFING0000128218.33
266Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)FING0000114318.32
267Early-onset myasthenia gravisGCST9009346518.25
268Blood cell traits latent factor 17 (white cell)GCST9055925918.20
269DermatitisFING0000040118.16
270Blood cell traits latent factor 23 (white cell)GCST9055926518.16
271Mean corpuscular hemoglobin concentrationGCST9001874518.11
272Lichen simplex chronicus and prurigoFING0000072518.08
273CXCL16/NOTCH1 ratioGCST9031433918.03
274CRTAP levelsGCST9046887217.88
275Obesity | endocrine/metabolicUKBB0000054417.82
276Blood cell traits latent factor 20 (red cell)GCST9055926217.81
277Obesity | Obesity and other hyperalimentationUKBB0000054517.80
278Mean corpuscular hemoglobin concentrationGCST9000232917.72
279Rheumatoid arthritis | musculoskeletalUKBB0000075717.69
280Lymphocyte percentage (UKB data field 30180)GCST9046808317.66
281ACYP1 levelsGCST9046821417.63
282DTI TBSS L3 Sagittal stratum LGCST9038455517.62
283Chronic lymphocytic leukemiaGCST9062473817.62
284Mean reticulocyte volumeGCST9002597517.51
285Right-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST9030281117.49
286Lymphoid neoplasms (P-cell phenocluster)GCST9062473717.35
287Blood cell traits latent factor 12 (red cell)GCST9055925417.34
288ChalazionFING0000026717.34
289Acute upper respiratory infectionsFING0000003417.27
290S100A11/S100A12 ratioGCST9031579817.27
291Non-albumin protein levelsUKBB0000050317.25
292Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complicationsGCST9009311317.20
293Infective dermatitisFING0000067317.17
294COPD/asthma/ILD related infectionsFING0000035317.17
295SNRPB2 levelsGCST9047069717.12
296Celiac disease (PheCode 557.1)GCST9004415817.11
297Lymphocyte percentage of white cellsGCST9000238917.10
298CC2D1A/STAMBP ratioGCST9031366417.03
299MZB1/TNFRSF13B ratioGCST9031550916.93
300Acute pancreatitisFING0000002716.91
301KLF4 levelsGCST9046969416.88
302CRTAM/GZMA ratioGCST9031427516.84
303Bipolar disorderGCST00372416.81
304Attendance/disability/mobility allowance - None of the above | Other sociodemographic factorsUKBB0000005916.79
305CD101 levelsGCST9046859616.77
306Mean reticulocyte volume | Blood countUKBB0000045116.73
307Primary biliary cholangitis (PBC)FING0000121116.73
308Seronegative rheumatoid arthritisFING0000129616.69
309CRTAM/ICAM3 ratioGCST9031427616.48
310Poisoning by antibiotics | injuries & poisoningsUKBB0000065316.44
311mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST9047544416.43
312KLRF1 levelsGCST9046971216.42
313Treatment/medication code - ventolin 100micrograms inhaler | MedicationsUKBB0000086016.42
314Wheeze or whistling in the chest in last year | BreathingUKBB0000091216.40
315Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35)GCST9030936916.37
316Omega-3 fatty acids to total fatty acids percentageGCST9050246016.31
317EZR levelsGCST9046916216.31
318LAT/LYN ratioGCST9031528316.31
319HayfeverGCST9046813116.27
320ICD10 N84: Polyp of female genital tractGCST9045421616.25
321Inflammatory bowel diseaseGCST9043218216.23
322Skin cancerGCST9047557516.20
323PPP1R2/TBL1X ratioGCST9031572016.19
324lymphocyte (fraction, mean, inv-norm transformed)GCST9047543516.19
325SH3GLB2 levelsGCST9047062116.11
326DTI TBSS L3 Cingulum hippocampus RGCST9038456016.08
327Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)FING0000077716.05
328aseg lh volume HippocampusGCST9000262416.04
329lymphocyte (fraction, minimum, inv-norm transformed)GCST9047543816.00
330Crohn's disease NASFING0000036715.90
331AsthmaGCST9047525915.89
332lymphocyte (fraction, maximum, inv-norm transformed)GCST9047543215.86
333TIGIT levelsGCST9047086515.82
334AsthmaGCST9047602415.80
335Doctor diagnosed hayfever or allergic rhinitis | Medical informationUKBB0000019215.80
336Cancer of urinary organs (incl. kidney and bladder) (PheCode 189)GCST9047559315.72
337STX6 levelsGCST9047077415.68
338KDM3A levelsGCST9046967115.64
339HippSubfield lh volume Whole-hippocampusGCST9000268915.60
340Ulcerative colitisGCST00413315.57
341Multiple myeloma or monoclonal gammopathy of undetermined significanceGCST9062474615.42
342Dissociative [conversion] disordersFING0000046815.38
343Omega-3 fatty acids to total fatty acids percentageGCST9050244815.37
344DTI TBSS MD Superior corona radiata LGCST9038459715.37
345Principal component-derived dietary pattern 9GCST9013301415.31
346Ceramide (d18:2/24:1) levelsGCST9002468415.31
3475alpha-pregnan-3beta,20alpha-diol monosulfate (2) levelsGCST9019985415.28
348TRAF2/WWP2 ratioGCST9031594315.24
349mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST9047544815.24
350DTI autoptx MD cgc l tractGCST9038522415.19
351CCL19 levelsGCST9046857115.18
352ICD10 O60: Preterm labor and deliveryGCST9045424215.16
353Benign leiomyoma with endometriosis (controls excluding all cancers)FING0000014515.11
354HippSubfield lh volume CA4-headGCST9000268215.09
355SRP14 levelsGCST9047074215.04
356IFNG levelsGCST9046951515.01
357ATP5IF1/LYN ratioGCST9031338914.99
358NBN levelsGCST9047000214.97
359TNFRSF11A levelsGCST9027764414.97
360IL15/NCR1 ratioGCST9031515014.95
361Asthma-related pneumoniaFING0000011914.94
362Average total household income before tax | HouseholdUKBB0000008114.94
363BCL2 levelsGCST9046843314.94
364Ceramide (d18:2/22:0) levelsGCST9002405414.92
365Rheumatoid arthritis and other inflammatory polyarthropathies | musculoskeletalUKBB0000075814.73
366CWC15 levelsGCST9046892014.61
367TPSAB1 levelsGCST9047095114.61
368Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitorUKBB0000070614.60
369Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitorUKBB0000069414.60
370Lymphoid leukemia, chronic (PheCode 204.12)GCST9047561314.57
371IGLC2 levelsGCST9046953614.56
372F2R/SNX9 ratioGCST9031473614.56
373Other demyelinating diseases of the central nervous systemFING0000099514.54
374DTI TBSS MD Posterior limb of internal capsule LGCST9038459114.54
375Other non-epithelial cancer of skin (PheCode 172.2)GCST9047558014.52
376Vitamin B12 deficiency anaemiaFING0000144114.52
377GZMA/LTA ratioGCST9031501214.49
378Squamous cell carcinoma (PheCode 172.22)GCST9047558314.45
379ENO2/RWDD1 ratioGCST9031466714.44
380CD5/IL16 ratioGCST9031386114.41
381FCRL5/TNFRSF13B ratioGCST9031480514.37
382GZMA/TNFRSF8 ratioGCST9031501414.32
383SarcoidosisFING0000127514.30
384CD27/TNFRSF9 ratioGCST9031377814.27
385Rheumatoid arthritis (PheCode 714.1)GCST9047623014.22
386PCBD1 levelsGCST9047016614.21
387PDCD1/TNFRSF4 ratioGCST9031560914.14
388CEACAM8/PGLYRP1 ratioGCST9031400314.12
389Takes medication for Skin condition (ex. Eczema, Psoriasis)?GCST9047527514.10
390ROR1/THBD ratioGCST9031578614.10
391Skin cancerGCST9047518914.07
392ZNF830 levelsGCST9047110214.06
393MAPRE3 levelsGCST9046985914.05
394Principal component-derived dietary pattern 26GCST9013303114.01
395Chronic dermatitis due to solar radiation (PheCode 938.2)GCST9047628814.00
396IL5RA levelsGCST9046960014.00
397Mood swings | Mental healthUKBB0000048213.91
398ALB/Globulin ratioUKBB0000002013.90
399Mean sphered cell volume (UKB data field 30270)GCST9046808913.85
400CD27/NECTIN4 ratioGCST9031377513.84
401Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary AdministrationUKBB0000083713.77
402LHPP levelsGCST9046976813.74
403CCL8 levelsGCST9042234613.74
404APBB1IP/POLR2F ratioGCST9031330013.68
405CRTAM/PDCD1 ratioGCST9031427913.66
406Frequency of stair climbing in last 4 weeks | Physical activityUKBB0000026613.65
407SMPD3 levelsGCST9047068513.60
408Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24)GCST9030935813.60
409GZMA/TNFRSF4 ratioGCST9031501313.59
410Dermatomycosis (PheCode 110.2)GCST9047556513.58
411ARHGAP25/RNF41 ratioGCST9031334513.57
412Prescriptions - paracetamol | antipyreticUKBB0000069613.56
413Prescriptions - antipyreticUKBB0000066513.56
414Diseases of the digestive systemFING0000042913.52
415DTI TBSS L1 Cingulum cingulate gyrus LGCST9038446313.49
416Regional enteritis (PheCode 555.1)GCST9047606613.48
417FCRL5/ICAM3 ratioGCST9031480213.48
418Juvenile rheumatoid arthirtisFING0000070613.39
419Prescriptions - antispasmodicUKBB0000066613.34
420Other noninfective gastroenteritis and colitisFING0000107713.32
421HEXIM1/TBL1X ratioGCST9031505313.31
422Diseases of white blood cells (PheCode 288)GCST9047581213.30
423PDCD5 levelsGCST9047018213.29
424Lymphocyte percentage of white cellsGCST00463213.23
425PRG2 levelsGCST9047032213.22
426HippSubfield lh volume CA4-bodyGCST9000268313.21
427Wheeze or whistling in the chest in last year (UKB data field 2316)GCST9004361413.17
428Melanomas of skin, dx or hx (PheCode 172.1)GCST9047557713.16
429PRG3 levelsGCST9047032313.12
430Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST9066852413.12
431T1 FreeSurfer DK rh supramarginal volumeGCST9038578713.12
432Other acute lower respiratory infectionsFING0000092113.10
433ATOX1/SNAP29 ratioGCST9031337413.10
434CD7 levelsGCST9046864913.08
435APRT levelsGCST9046834513.08
436ELOA/POLR2F ratioGCST9031464313.08
437SMNDC1 levelsGCST9047068113.05
438Peripheral or central vertigo (PheCode 386.2)GCST9047590712.98
439PM: initial answer - Orange circle| Prospective memoryUKBB0000065212.96
440mean corpuscular volume (MCV, minimum, inv-norm transformed)GCST9047547412.94
441IDP dMRI TBSS L1 Posterior limb of internal capsule RGCST9000409312.93
442Ever SmokerFING0000052212.90
443HippSubfield lh volume Whole-hippocampal-bodyGCST9000268712.90
444Urine N-acetylglutamate levels in chronic kidney diseaseGCST9026556912.89
445Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448)GCST9013296812.86
446ITGB1BP2/TIA1 ratioGCST9031522212.85
447CD48/SLAMF7 ratioGCST9031384212.82
448CEP43/MPHOSPH8 ratioGCST9031401912.80
449EDAR/TACC3 ratioGCST9031458912.77
450Mean reticulocyte volume (UKB data field 30260)GCST9046808812.75
451KCTD5 levelsGCST9046967012.74
452Nonspecific chest pain | circulatory systemUKBB0000052712.74
453Erythematous conditions (PheCode 695)GCST9047617712.70
454CDSN/WFDC12 ratioGCST9031399912.69
455Basal cell carcinoma (PheCode 172.21)GCST9047558212.68
456Psoriatic arthropathiesFING0000122512.68
457Vanillactate levelsGCST9019997812.65
458IL10 levelsGCST9046954612.63
459IL22 levelsGCST9046958212.61
460DNMBP/WWP2 ratioGCST9031452212.58
461Solitary pulmonary nodule (PheCode 514.2)GCST9047604412.55
462Disorders of sclera, cornea, iris and ciliary bodyFING0000045812.55
463INPP5J levelsGCST9046961812.52
464Ulcerative rectosigmoiditisFING0000139412.50
465Biological Sibling: AsthmaGCST9047637212.46
466Ulcerative colitisGCST9044679512.44
467mean corpuscular volume (MCV, mean, inv-norm transformed)GCST9047547012.39
468Primary sclerosing cholangitisGCST00403012.36
469MICB or MICA levelsGCST9046990512.34
470Pollen allergyFING0000117612.32
471Mean sphered cell volume | Blood countUKBB0000045212.29
472mean corpuscular volume (MCV, maximum, inv-norm transformed)GCST9047546612.22
473CD27/TNFRSF13B ratioGCST9031377712.22
474TNFRSF13B/TNFSF13B ratioGCST9031593312.21
475MAVS/MED18 ratioGCST9031538912.17
476FCRL6/GZMA ratioGCST9031480612.15
477B2M levelsGCST9046840912.11
478DKK1/IPCEF1 ratioGCST9031447112.09
479Plasma ascorbic acid 2-sulfate levels in chronic kidney diseaseGCST9026483212.04
480Other specified disorders of external earFING0000110412.04
481SLITRK2 levelsGCST9047067012.03
482GZMH/KLRD1 ratioGCST9031501612.00
483KLRK1 levelsGCST9046971311.98
484Ulcerative colitisGCST9001871311.96
485IDP dMRI ProbtrackX L1 ifo rGCST9000425911.95
486Current SmokerFING0000037111.88
487Taking other prescription medications | MedicationUKBB0000081311.87
488Cerebrospinal fluid methylmalonate (MMA) levelsGCST9031824311.85
489Uterine fibroidsGCST9046195811.80
490Blood cell traits latent factor 3 (white cell)GCST9055924511.79
491Nasal polypsGCST9046814311.78
492PollinosisGCST9001868311.78
493Mean reticulocyte volumeGCST9000239611.77
494GBP1 levelsGCST9046931111.74
495Crohn's disease of small intestineFING0000036911.71
496CD27 levelsGCST9046861511.68
497aparc-a2009s rh thickness G-temporal-middleGCST9000371411.66
498AHCY/HSPA1A ratioGCST9031321111.61
499Basal cell carcinomaGCST9001341011.57
500HippSubfield lh volume GC-ML-DG-bodyGCST9000268111.56
501BCR/FOXO1 ratioGCST9031349011.53
502MelanomaGCST9001180911.51
503CD244 levelsGCST9046861111.50
504TP53BP1 levelsGCST9047093611.47
505T1 FreeSurfer aseg Right-choroid-plexusGCST9038417011.43
506ITGB7 levelsGCST9046964711.42
507DNA methylation PhenoAge accelerationGCST9001429211.41
508IPCEF1/SERPINE1 ratioGCST9031518411.39
509CD27/CD79B ratioGCST9031377011.37
510Ulcerative colitis (strict definition, require KELA, min 2 HDR)FING0000138811.36
511PTPRC levelsGCST9047038011.36
512Red blood cell countGCST9001875111.35
513Lumbar disc prolapseFING0000073511.32
514TRAF3 levelsGCST9047095711.27
515ATP5IF1/METAP1D ratioGCST9031339111.24
516Operation code - hysterectomy | OperationsUKBB0000055911.23
517Cervicalgia (PheCode 761)GCST9047626711.18
518Basophil countGCST9000229311.17
519ENO2/PLXNA4 ratioGCST9031466511.16
520Bread type - Wholemeal or wholegrain | DietUKBB0000010711.15
521Number of attempts | Prospective memoryUKBB0000053111.10
522SUMF1 levelsGCST9047078311.06
523LRRC37A2 levelsGCST9046980211.04
524Types of physical activity in last 4 weeks - None of the above | Physical activityUKBB0000087211.03
525IFI30 levelsGCST9046950910.99
526FUT8/TNFSF14 ratioGCST9031489510.98
527CD48 levelsGCST9046863510.98
528Prescriptions - albuterol | beta2-agonist,bronchodilator,asthmaUKBB0000065810.94
529Prescriptions - beta2-agonist|bronchodilator|asthmaUKBB0000067010.94
530DAG1/F2R ratioGCST9031437410.92
531HEXIM1/TRIAP1 ratioGCST9031505410.92
532Strenuous sports or other exercisesGCST00610010.92
533Endometrial cancerGCST00646410.91
534PAXX levelsGCST9047016110.88
535Atopic dermatitisGCST9001856410.83
536Asthma, unspecified (mode)FING0000012010.81
537T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78)GCST9032064110.79
538General happiness | Happiness and subjective well-beingUKBB0000028010.78
539EDAR/LAT2 ratioGCST9031458210.77
540DTI TBSS L2 External capsule LGCST9038450910.76
541BOLA2 or BOLA2B levelsGCST9046846010.74
542FOXO3/SH2B3 ratioGCST9031488110.73
543ICD10 N97.8: Female infertility of other originGCST9045422510.71
544Diseases of esophagus (PheCode 530)GCST9047604510.70
545LTA4H levelsGCST9046981210.70
546UrticariaFING0000140810.68
547mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed)GCST9047544210.65
548HSPA1A levelsGCST9046948710.65
549BCR/ITGB1BP2 ratioGCST9031349410.64
550Mean spheric corpuscular volumeGCST9000239710.58
551IDP T1 FIRST left hippocampus volumeGCST9000244410.56
552MED18/TBL1X ratioGCST9031541510.55
553Scar conditions and fibrosis of skin (PheCode 701.2)GCST9047619810.53
554Neoplasm of uncertain behavior of skin (PheCode 173)GCST9047558510.53
555mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST9047544610.50
556SELPLG levelsGCST9047056810.45
557Alcohol-induced chronic pancreatitisFING0000005510.45
558Actinic keratosis (PheCode 702.1)GCST9047620410.44
559CD69/EDAR ratioGCST9031387510.42
560Interpolated Age of participant when non-cancer illness first diagnosed | Medical conditionsUKBB0000036910.42
561MAP2K6/TBL1X ratioGCST9031537810.41
562Crohns diseaseGCST9046812110.40
563Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivityGCST9030267310.40
564Pain in throat and chest | Symptoms and signs involving the circulatory and respiratory systemsUKBB0000062510.40
565IL2RA levelsGCST9046958510.40
566ARG1 levelsGCST9046835010.36
567Hair colour (natural, before greying): Red (UKB data field 1747_2)GCST9004183710.35
568PM: initial answer - Blue square | Prospective memoryUKBB0000065110.34
569BTN3A2 levelsGCST9046848110.34
570Colitis, primary sclerosing, strict definitionFING0000031310.33
571IL18 levelsGCST9042841110.33
572Ulcerative colitis (PheCode 555.2)GCST9004415510.31
573LBR/LGALS8 ratioGCST9031529410.30
574mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST9047545010.27
575Symptoms involving digestive system (PheCode 561)GCST9047606910.24
576Idiopathic pulmonary fibrosisFING0000065910.24
577ENO3 levelsGCST9046911110.22
578SPESP1 levelsGCST9047072010.21
579Psoriasis (vulgaris), strict definitionFING0000122310.20
580SNAP23/TBL1X ratioGCST9031585610.16
581CRACR2A/LBR ratioGCST9031422810.16
582CA1/HMBS ratioGCST9031357310.15
583TSC1 levelsGCST9047097210.15
584Bread type: Wholemeal or wholegrain (UKB data field 1448_3)GCST9013296610.14
585Late-onset myasthenia gravisGCST9009346610.12
586CD74/NPDC1 ratioGCST9031389510.11
587Citrulline levelsGCST9020040310.11
588GSTA4 levelsGCST9024128310.09
589Volume of right cortical nucleusGCST9047503310.09
590Never eat wheat vs no wheat restrictions (UKB data field 6144)GCST9013293210.08
591Crohn's diseaseGCST9044679310.07
592Symptoms concerning nutrition, metabolism, and development (PheCode 1002)GCST9047555610.07
593CCL17/CD69 ratioGCST9031368410.04
594IDP dMRI TBSS OD Posterior limb of internal capsule RGCST9000442010.04
595MSRA/PRDX5 ratioGCST903154979.96
596Rheumatoid arthritis and other inflammatory (PheCode 714)GCST904762289.95
597DTI autoptx L1 cst r tractGCST903851489.94
598CXCL16 levelsGCST902405249.93
599ERBIN/LYN ratioGCST903146949.92
600TNFSF13B levelsGCST904709209.92
601Atrophic disorders of skinFING000001299.91
602CDA levelsGCST904686609.90
603Treatment or medication use - insulin product (UKB data field 20003_1140883066)GCST900422269.90
604Rosacea (PheCode 695.3)GCST904761789.89
605CEP85 levelsGCST904687169.88
606ICD10 N87: Dysplasia of cervix uteriGCST904542189.82
607LY96 levelsGCST904698239.82
608Spondylopathies (FG)FING000013269.80
609RILP levelsGCST904704719.79
610Crohn's diseaseGCST0041329.77
611TALDO1 levelsGCST904708029.77
612Sporadic miscarriageGCST0118889.76
613EDAR/F2R ratioGCST903145779.75
614CXCL5/MESD ratioGCST903143509.75
615Dried fruit consumptionGCST901329809.71
616CXCL5/PLXNA4 ratioGCST903143519.67
617Disorders of plasma protein metabolism (PheCode 270.3)GCST904757099.66
618Melanomas of skin (PheCode 172.11)GCST904755789.66
619Internal derangement of knee (PheCode 835)GCST904762829.65
620Other intervertebral disc disordersFING000010639.64
621Ankylosing spondylitis, strict definitionFING000000909.63
622N-acetylmethionine levelsGCST902002899.63
623T1 CAT volume R RightThalamusGCST903840979.63
624Other and unspecified tonsillitisFING000009549.63
625DNAJB14 levelsGCST904272359.61
626Lung cancerGCST900186559.59
627Malignant neoplasm, excluding all cancers (controls excluding all cancers)FING000007809.59
628PSAPL1 levelsGCST902423549.58
629PEAR1/PECAM1 ratioGCST903156419.58
630Degenerative skin conditions and other dermatoses (PheCode 702)GCST904762029.56
6315alpha-pregnan-3beta,20alpha-diol disulfate levelsGCST901998389.50
632Ankylosing spondylitisFING000000899.48
633Ulcerative colitisGCST904753229.46
634CDC27 levelsGCST904686649.45
635Mean corpuscular volumeGCST900023929.45
636FCRL5 levelsGCST904692089.44
637Non-allergic asthma (mode) (more control exclusions)FING000008699.43
638UGDH levelsGCST904710069.43
639Acquired hypothyroidism (PheCode 244.2)GCST904756509.42
640Ulcerative enterocolitisFING000013919.41
641GBP4 levelsGCST904693139.39
642DBNL/EDAR ratioGCST903144169.38
643Handedness (chirality/laterality) - Right-handed | Early life factorsUKBB000003039.36
644T1 FreeSurfer BA lh BA2 exvivo volumeGCST903855349.34
645CA3/HMBS ratioGCST903135849.33
646rfMRI connectivity (ICA100 edge 605)GCST900054589.32
647aparc-a2009s rh thickness G-oc-temp-med-LingualGCST900036989.32
648SPINK2 levelsGCST904707229.31
649Dried fruit likingGCST900947569.30
650Irritable bowel syndromeFING000007029.29
651X-11550 levelsGCST902436489.29
652Mean corpuscular volume (UKB data field 30040)GCST904680869.26
653CRACR2A/IRAG2 ratioGCST903142279.26
654APP/HBEGF ratioGCST903133249.25
655CCR2 on CD14+ CD16- monocyteGCST900020049.25
656Acute upper respiratory infections of multiple and unspecified sitesFING000000359.24
657Right-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST903027999.23
658EDAR/EGF ratioGCST903145739.22
659AHSP/HMBS ratioGCST903132179.20
660GRHPR levelsGCST904694009.20
661Allergic rhinitisFING000000719.20
662Treatment/medication code - ibuprofen | MedicationsUKBB000008479.19
663Active to sedentary transition probabilityGCST900614299.17
664JCHAIN levelsGCST904696619.16
665CXCL11/DKK1 ratioGCST903143349.16
666T1 FreeSurfer DKT rh supramarginal volumeGCST903843779.12
667MPHOSPH8/USP8 ratioGCST903154799.11
668BAG6/BMP6 ratioGCST903134509.09
669ST13 levelsGCST904707519.07
670aparc-Desikan rh volume insulaGCST900028349.07
671CD6/EZR ratioGCST903138909.07
672CPXM1/HBEGF ratioGCST903142199.06
673DNA methylation-estimated granulocyte proportionsGCST900142879.05
674Left-hemisphere dorsal attention network to putamen white-matter structural connectivityGCST903027039.05
675Myasthenia gravisGCST900930619.04
676Chronic obstructive pulmonary disease in current smokersGCST900165939.04
677Non-cancer illness code, self-reported - osteoarthritis | Medical conditionsUKBB000005219.03
678Right-hemisphere visual network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027769.01
679Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763)GCST904762689.00
680Prospective memory result | Prospective memoryUKBB000007138.98
681RAPGEF2 levelsGCST904704268.98
682CDSN/LY6D ratioGCST903139978.96
683Follicular lymphoma, hilmo (controls excluding all cancers)FING000005488.93
684Triacylglycerol_52:5_[M+NH4]1+ levelsGCST900605068.93
685FOXO1/USP8 ratioGCST903148798.93
686Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST906687588.92
687Belief that own life is meaningful | Happiness and subjective well-beingUKBB000000908.91
688DTI autoptx L3 ifo l tractGCST903852058.90
689Principal component-derived dietary pattern 42GCST901330478.90
690OsteoarthritisGCST904681448.89
691CDKN2D/FOXO1 ratioGCST903139858.89
692Vertiginous syndromes and other disorders of vestibular system (PheCode 386)GCST904759058.88
693Time spent watching television (TV) | Physical activityUKBB000008218.88
694T1 FreeSurfer a2009s lh S postcentral areaGCST903847348.86
695CD40LG/TRAF2 ratioGCST903138288.86
696Mean corpuscular hemoglobinGCST900023908.85
697Educational attainmentGCST0025988.81
698Hepatic cancerGCST900186388.81
699MICB_MICA/TEK ratioGCST903154468.78
700LAYN/PTPRN2 ratioGCST903152908.77
701aparc-a2009s rh volume S-collat-transv-antGCST900030488.77
702TNFRSF9 levelsGCST904709168.77
703Suppurative and unspecified otitis mediaFING000013468.77
704Fluid intelligence score decline (difference score)GCST905658628.76
705CALCOCO1/TJAP1 ratioGCST903136118.76
706Telomere length (principal component 1)GCST904351448.76
707TNF/TNFRSF1B ratioGCST903159428.71
708N-acetyl-2-aminoadipate levelsGCST902002688.70
709RIDA levelsGCST904704698.69
710PBLD levelsGCST904701638.68
711DTI autoptx MD str r tractGCST903852448.65
712LPCAT2/SERPINB8 ratioGCST903153288.63
713Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)FING000007728.62
714PLXNB3/SNAP23 ratioGCST903156938.62
715CALCOCO1/TBC1D5 ratioGCST903136108.62
716Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144)GCST901329318.61
717IDP dMRI ProbtrackX L1 str lGCST900042698.58
718LSP1 levelsGCST904698118.57
719RAP1A levelsGCST904704258.57
720FOXO1/NFATC1 ratioGCST903148738.55
721IL2RA/NCR1 ratioGCST903151618.55
722NELL1 levelsGCST902424818.54
723Other contact dermatitisFING000009908.53
724DCTN1/TRIAP1 ratioGCST903144348.51
725DTI TBSS MD Cingulum cingulate gyrus LGCST903846078.49
726Esophagitis, GERD and related diseases (PheCode 530.1)GCST904760468.44
727EDAR/SNAP23 ratioGCST903145878.43
728Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classifiedFING000004328.43
729TP53I3 levelsGCST904709378.42
730NELL2/SEZ6L ratioGCST903155368.41
731Acute renal failureFING000000308.40
732Spondylosis without myelopathy (PheCode 721.1)GCST904762368.40
733FOXO3 levelsGCST904692668.39
734Long-standing illness, disability or infirmity | General healthUKBB000004098.38
735EBAG9/TBCC ratioGCST903145688.36
736Uterine fibroidsGCST904681548.33
737Psoriatic arthritis vs Cutaneous psoriasisGCST902439578.28
738LY6D/WFDC12 ratioGCST903153468.28
739UCMA levelsGCST902432858.25
740GIMAP7 levelsGCST904693458.25
741N-acetyl-1-methylhistidine levelsGCST902006908.23
742Red blood cell countGCST900023648.23
743CataractsGCST900185948.22
744Eosinophil count varianceGCST905656898.22
745EDAR/ERBIN ratioGCST903145758.21
746MINPP1 levelsGCST902419788.21
747aparc-a2009s rh area S-collat-transv-antGCST900034208.19
748Plasma taurocholenate sulfate* levels in chronic kidney diseaseGCST902660408.18
749VSTM2B levelsGCST904710568.18
750MAN2B2 levelsGCST904698448.15
751DTI TBSS MD Anterior limb of internal capsule LGCST903845898.14
752FCRL1/TCL1A ratioGCST903147958.14
753HAVCR2 levelsGCST904215158.14
754EFNA4/TNFRSF9 ratioGCST903146068.13
755BA-exvivo lh volume BA2GCST900028368.07
756Dried fruit intake | DietUKBB000001938.07
757Other circulatory problemGCST904752178.07
758Other cancerGCST904751818.05
759Avocado likingGCST900946948.02
760CDH17/PTPRM ratioGCST903139438.01
761Mouth/teeth dental problems - Bleeding gums | MouthUKBB000004858.01
762T1 FreeSurfer aseg Right-PallidumGCST903841648.01
763Number of days/week of vigorous physical activity 10+ minutes | Physical activityUKBB000005347.99
764ITGB1BP2/USP8 ratioGCST903152237.99
765Omega-3 fatty acid levelsGCST905024227.98
766Non-cancer illness code, self-reported - hiatus hernia | Medical conditionsUKBB000005157.98
767Other arthritis (FG)FING000009647.98
768Carboplatin drug response (IC50)GCST900117837.97
769DAB2/FKBP1B ratioGCST903143627.97
770Lymphangioleiomyomatosis (sporadic)GCST0083117.96
771Polymyalgia rheumaticaFING000011887.96
772C5 levelsGCST904685007.95
773Other systemic involvement of connective tissue (FG)FING000011167.95
774Multiple myelomaGCST906247477.93
775Cerebral aneurysm, nonrupturedFING000002637.93
776AHNAK levelsGCST904682617.93
777T1 CAT volume L VIIIaGCST903841277.92
778FCRL6/KLRD1 ratioGCST903148077.92
779Snoring | SleepUKBB000007847.89
780Rhodanobacter abundance in stoolGCST900325367.88
781CD22/SEMA7A ratioGCST903137597.88
782CCL5/TACC3 ratioGCST903137077.86
783Diseases of middle ear and mastoidFING000004277.84
784Neoplasm of uncertain behavior (PheCode 199)GCST904756067.84
785IPCEF1/TBCC ratioGCST903151887.84
786DAPP1/ITGB1BP2 ratioGCST903143887.83
787Left-hemisphere salience/ventral attention network to amygdala white-matter structural connectivityGCST903027247.82
788CAPG levelsGCST904685377.81
789DTI autoptx FA slf l tractGCST903851337.80
790COX5B/GFER ratioGCST903142007.79
791DTI TBSS MD Superior longitudinal fasciculus LGCST903846137.78
792CDKN2D/TACC3 ratioGCST903139927.78
793Ratio of bis-allylic bonds to double bonds in lipidsGCST901327447.78
794Mean corpuscular haemoglobin (UKB data field 30050)GCST904680847.78
795DTI autoptx L1 cst l tractGCST903851477.77
796GERD (PheCode 530.11)GCST904760477.77
797DTI TBSS L3 Sagittal stratum RGCST903845547.77
798Basophil countGCST900187267.76
799MAP2K1 levelsGCST904698517.75
800TNFRSF13B/TNFRSF9 ratioGCST903159327.74
801EGLN1 levelsGCST904690877.73
802DTI TBSS MD Posterior thalamic radiation RGCST903846007.71
803Principal component-derived dietary pattern 28GCST901330337.70
804TFRC levelsGCST904708407.70
805TNFSF12 levelsGCST902748467.68
806CD300A levelsGCST904686197.65
807Smoking status (standard GWA)GCST902673027.65
808GRAP2/MAP4K5 ratioGCST903149827.65
809Mean corpuscular hemoglobinGCST0046307.64
810ESAM/FUT8 ratioGCST903147117.63
811HMBS/PKLR ratioGCST903150637.62
812Spondylosis and allied disorders (PheCode 721)GCST904762357.61
813Number of days/week walked 10+ minutes | Physical activityUKBB000005357.58
814BOC levelsGCST904684587.57
815mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)GCST904754567.57
816Mean corpuscular volume | Blood countUKBB000004497.53
817TXNDC15 levelsGCST904709907.53
818Tryptophan betaine levelsGCST901998197.53
819Principal component-derived dietary pattern 21GCST901330267.52
820LCN2/PGLYRP1 ratioGCST903153067.51
821Margaroylcarnitine (C17) levelsGCST901999297.51
822PSIP1 levelsGCST904703547.50
823ConjunctivitisFING000003467.49
824ITGB1BP2/WASF1 ratioGCST903152247.47
825GOPC/IRAK4 ratioGCST903149547.47
826Crohn's diseaseGCST904753187.46
827CALCOCO1/IRAG2 ratioGCST903136047.45
828CD58/MEGF10 ratioGCST903138537.45
829Peripheral enthesopathies and allied syndromes | musculoskeletalUKBB000006407.45
830LCN2/S100A12 ratioGCST903153097.42
831PPM1B levelsGCST904702967.42
832SnoringGCST0097627.42
833PRKAB1 levelsGCST904703247.42
834IDP dMRI TBSS L1 Posterior limb of internal capsule LGCST900040947.40
835Basal cell carcinoma, excluding all cancers (controls excluding all cancers)FING000001427.39
836Handedness (confirmatory factor analysis Factor 36)GCST903093707.36
837AHSP/BLVRB ratioGCST903132147.35
838Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)FING000001437.34
839BleedingFING000002197.33
840SLAMF1 levelsGCST902748357.33
841DTI autoptx L2 slf l tractGCST903851877.33
8423-methyl-2-oxobutyrate levelsGCST901996777.31
843IPCEF1/SPARC ratioGCST903151867.30
844All pneumoniaeFING000000657.29
845ADA levelsGCST904682317.29
846CRTAM/KLRD1 ratioGCST903142777.28
847Eosinophil percentage of white cells varianceGCST905656907.27
848NFATC3 levelsGCST904700347.25
849Neutrophill percentage | Blood countUKBB000004987.24
850IL16 levelsGCST904695577.24
851FUT8/RSPO1 ratioGCST903148917.22
852Mean corpuscular volumeGCST0046027.22
853MAP3K5/MAVS ratioGCST903153797.21
854TCL1A/TNFRSF13C ratioGCST903159127.20
855Omega-3 fatty acids to total fatty acids percentageGCST905020877.17
856THBS2 levelsGCST904708547.16
857CDKN2D/ITGB1BP2 ratioGCST903139877.16
858Raynauds phenomenon diseaseGCST902717137.15
859PFKM levelsGCST906188027.15
860Tobacco use disorder | mental disordersUKBB000008247.12
861Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74)GCST906685187.12
862PRKAR1A/SNAP23 ratioGCST903157287.11
863Allergic conjunctivitisFING000000677.10
864Medication use (immunosuppressants)GCST900187717.10
865Neutrophil percentage of white cellsGCST900023997.09
866C1R levelsGCST904684937.07
867Prostate cancerGCST900186857.06
868KYNU/SCLY ratioGCST903152657.05
869GZMA levelsGCST904694237.04
870Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020747.04
871Neutrophill percentage (UKB data field 30200)GCST904680937.04
872FCER1A levelsGCST904691987.03
873PARP1 levelsGCST904701607.03
874Methods of admission to hospital (recoded) - Elective admission: Booked | Summary AdministrationUKBB000004617.01
875APEX1 levelsGCST904683297.00
876Mean corpuscular haemoglobin | Blood countUKBB000004477.00
877TNFRSF19 levelsGCST900889476.98
878T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 48)GCST903206116.98
879Dermatitis due to ingested foodFING000004036.97
880Thyroid cancer (PheCode 193)GCST904756006.94
881CXCL5/PPIB ratioGCST903143526.93
882Chronic hepatitis B infectionGCST900185846.93
883Pilonidal cystFING000011676.93
884Overweight, obesity and other hyperalimentation (PheCode 278)GCST904757596.92
885DTI autoptx L3 ilf l tractGCST903852076.91
886SNAP23/TXLNA ratioGCST903158576.90
887HBEGF/WWP2 ratioGCST903150386.90
888CALCOCO1/PDLIM7 ratioGCST903136076.87
889Principal component-derived dietary pattern 12GCST901330176.87
890DTI TBSS L3 Posterior thalamic radiation RGCST903845526.87
891Poultry consumptionGCST901329966.86
892DTI autoptx L3 slf r tractGCST903852156.86
893NAP1L4 levelsGCST904699986.85
894IDP dMRI TBSS MD Posterior limb of internal capsule RGCST900040456.84
895Gastroesophageal reflux diseaseGCST900005146.84
896Hair colour (natural, before greying): Dark brown (UKB data field 1747_4)GCST900418396.82
897DTI TBSS MD Superior longitudinal fasciculus RGCST903846126.82
898APRT/CD63 ratioGCST903133346.81
899DNAJB2 levelsGCST904690136.81
900NPDC1/PTGDS ratioGCST903155496.81
901CDH17/PECAM1 ratioGCST903139426.78
902CD22/TCL1A ratioGCST903137606.76
903Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB000001676.75
904Hair colour (natural, before greying) - Dark brown | Sun exposureUKBB000002976.72
905Hernia abdominopelvic cavityGCST900860876.72
906Mean corpuscular hemoglobin concentrationGCST900023286.72
907COL1A1 levelsGCST902407446.71
908IDP T1 FAST ROIs L parahipp gyrus postGCST900025196.71
909EBAG9/FKBP5 ratioGCST903145646.68
910Cleft hard palate NOSFING000003066.68
911DTI autoptx FA ifo r tractGCST903851256.67
912PPP1R14D levelsGCST904703036.67
913Attendance/disability/mobility allowance - Disability living allowance | Other sociodemographic factorsUKBB000000586.67
914Back pain (PheCode 760)GCST904762666.67
915SPTLC1 levelsGCST904271306.66
916DiverticulitisGCST904681256.66
917STIP1 levelsGCST904707646.66
918IL32 levelsGCST904695916.66
919KIR3DL1 levelsGCST904696876.63
920Excessive vomiting in pregnancyFING000005236.63
921Usual side of head for mobile phone use - Left | Electronic device useUKBB000008896.62
922DTI TBSS L2 Posterior thalamic radiation RGCST903845046.62
923IPCEF1 levelsGCST904696246.61
924Dementia due to Parkinson's disease (more control exclusions)FING000003926.60
925PEBP1 levelsGCST904702056.58
926wg lh intensity-contrast rostralmiddlefrontalGCST900038186.57
927Tooth agenesis EXCLUDE clefts and syndromesFING000013686.56
928Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis?GCST904752736.53
929Pre-existing hypertension complicating pregnancy, childbirth and the puerperiumFING000012036.53
930Pregnenolone sulfate levelsGCST901998736.52
931Other dorsopathies, not elsewhere classifiedFING000010416.52
932CXCL3/CXCL5 ratioGCST903143446.52
933DCTN6/TDRKH ratioGCST903144366.52
934PLAUR levelsGCST900120516.51
935Cancer of bronchus; lung (PheCode 165.1)GCST904755736.51
936Mineral and other dietary supplements - Glucosamine | MedicationUKBB000004736.49
937T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101)GCST903209206.49
938Acute bronchitisFING000000216.49
939DTI autoptx MD slf r tractGCST903852426.48
940Chronic diseases of tonsils and adenoidsFING000002836.48
941CD84/F2R ratioGCST903139126.48
942ThalamNuclei lh volume MDlGCST900027246.47
943Main speciality of consultant (recoded) - Trauma and orthopaedics | Summary AdministrationUKBB000004206.47
944Other haemoglobinopathiesFING000010536.46
945DTI TBSS L1 Anterior corona radiata RGCST903844506.46
946IDP dMRI TBSS OD Posterior limb of internal capsule LGCST900044216.46
947CD20 on IgD- CD27- B cellGCST900017546.45
948ICAM4 levelsGCST904695016.45
949MED18/TACC3 ratioGCST903154146.44
950INSR levelsGCST904696236.44
951NECTIN2/NPDC1 ratioGCST903155286.44
952Educational attainment (confirmatory factor analysis Factor 10)GCST903093446.43
953CDH17/SPINT1 ratioGCST903139446.42
954Intrinsic epigenetic age accelerationGCST900142906.41
955ATP5IF1/FXN ratioGCST903133866.41
956neutrophil (fraction, mean, inv-norm transformed)GCST904755386.41
957PROK1 levelsGCST904703366.40
958DTI TBSS L3 Superior corona radiata LGCST903845496.40
959Mean corpuscular hemoglobin varianceGCST905656936.40
960Other disorders of glucose regulation and pancreatic internal secretionFING000010286.40
961Polyp of the female genital tractFING000011906.40
962AXIN1/ITGB1BP2 ratioGCST903134126.39
963VEGFB levelsGCST904710356.39
964Bread type - White | DietUKBB000001066.39
965DOK2/PDLIM7 ratioGCST903145356.39
966How are people in household related to participant - Husband, wife or partner | HouseholdUKBB000003306.37
967Thyrotoxicosis with or without goiter (PheCode 242)GCST904756436.37
968CD86 levelsGCST904686546.37
969IDP dMRI TBSS ISOVF Genu of corpus callosumGCST900044796.37
970PIKFYVE levelsGCST904702356.37
971CD72 levelsGCST904686466.37
972SLAMF1 levelsGCST904706496.35
973GFRA2 levelsGCST904693296.33
974FUT3 or FUT5 levelsGCST904692806.31
975Atrial septal defectFING000001286.31
976CLEC4D/CLEC6A ratioGCST903141096.30
977Cooked vegetable intake | DietUKBB000001476.29
978IL15/KLRD1 ratioGCST903151496.28
979SRC/TBL1X ratioGCST903158846.28
980RNF43 levelsGCST904704866.28
981AXIN1/MAVS ratioGCST903134146.26
982GDNF levelsGCST902747926.25
983BACH1/SNAP23 ratioGCST903134466.25
984Arachidoylcarnitine (C20) levelsGCST902001356.25
985Redundant prepuce, phimosis and paraphimosisFING000012466.23
986TLR4 levelsGCST904708806.22
987DTI TBSS L2 Superior longitudinal fasciculus LGCST903845176.21
988PLXNA4/USP8 ratioGCST903156906.20
989HLA-A levelsGCST904694576.20
990EBAG9/TGFB1 ratioGCST903145706.20
991neutrophil (fraction, maximum, inv-norm transformed)GCST904755356.19
992Hypoplasia of dental enamel, including avohilmoFING000006526.19
993BACH1/CD2AP ratioGCST903134356.18
994NMT1 levelsGCST904700596.18
995UNC5D levelsGCST904710106.17
996TOR1AIP1 levelsGCST904709356.17
997DTI TBSS MD Superior corona radiata RGCST903845966.14
998HBEGF/PLXNA4 ratioGCST903150366.11
999Never eat eggs, dairy, wheat, sugar - Sugar or foods/drinks containing sugar | DietUKBB000005016.11
1000FCRL3 levelsGCST904692076.10